We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTTX
4851
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$5.18K ﹤0.01%
4,799
-4,347
-48% -$4.21K
DMRA
4852
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.82B
$5.18K ﹤0.01%
82
-60
-42% -$3.27K
CVR icon
4853
Chicago Rivet & Machine Co
CVR
$9.95M
$5.17K ﹤0.01%
201
-80
-28% -$2.14K
PTPI
4854
DELISTED
Petros Pharmaceuticals
PTPI
$5.17K ﹤0.01%
102
+10
+11% +$779
ICU icon
4855
SeaStar Medical
ICU
$14.7M
$5.16K ﹤0.01%
40
+21
+111% +$6.28K
ZYNE
4856
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$5.16K ﹤0.01%
15,817
+15,733
+18,730% +$5.64K
ASYS icon
4857
Amtech Systems
ASYS
$264M
$5.14K ﹤0.01%
538
-4,409
-89% -$40K
CX icon
4858
Cemex
CX
$16.3B
$5.14K ﹤0.01%
726
-1,360
-65% -$8.65K
SOTK icon
4859
Sono-Tek
SOTK
$80.3M
$5.13K ﹤0.01%
950
-396
-29% -$2.11K
SDC
4860
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$5.13K ﹤0.01%
9,671
-7,821
-45% -$3.19K
BOTJ icon
4861
Bank Of The James
BOTJ
$123M
$5.12K ﹤0.01%
563
-854
-60% -$8.06K
ESOA icon
4862
Energy Services of America
ESOA
$288M
$5.12K ﹤0.01%
1,765
-5,359
-75% -$12.2K
GORO icon
4863
Goldgroup Mining Inc.
GORO
$186M
$5.12K ﹤0.01%
8,121
DLHC icon
4864
DLH Holdings
DLHC
$70.2M
$5.09K ﹤0.01%
497
-582
-54% -$5.97K
IMPL
4865
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$5.08K ﹤0.01%
4,000
+2,962
+285% +$4.49K
AXR icon
4866
AMREP Corp
AXR
$116M
$5.08K ﹤0.01%
283
-427
-60% -$6.45K
SPRB
4867
Spruce Biosciences
SPRB
$127M
$5.07K ﹤0.01%
31
-21
-40% -$3.51K
PZG icon
4868
Paramount Gold Nevada
PZG
$132M
$5.07K ﹤0.01%
16,089
-226
-1% -$73
SPEC
4869
DELISTED
Spectaire Holdings, Inc. Common Stock
SPEC
$5.06K ﹤0.01%
452
-10
-2% -$109
PSI icon
4870
Invesco Semiconductors ETF
PSI
$2.43B
$5.06K ﹤0.01%
111
-3,909
-97% -$158K
AVTX icon
4871
Avalo Therapeutics
AVTX
$1.06B
$5.04K ﹤0.01%
59
+49
+490% +$33K
PLBC icon
4872
Plumas Bancorp
PLBC
$427M
$5.03K ﹤0.01%
141
-494
-78% -$17.5K
CELC icon
4873
Celcuity
CELC
$4.43B
$5.02K ﹤0.01%
+457
New +$4.75K
FAT
4874
DELISTED
FAT Brands
FAT
$5.02K ﹤0.01%
1,308
-2,895
-69% -$10.2K
PST icon
4875
ProShares Trust UltraShort Lehman 7-10 Year Treasury
PST
$10.6M
$5K ﹤0.01%
+226
New +$4.82K

Similar funds

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.